Matches in Nanopublications for { ?s ?p "[Combined with abdominal obesity, epistasis in the VLDL pathway (lipoprotein lipase, apolipoprotein CIII, hepatic lipase, PARalpha, PPARgamma, and apo E genes) has a deleterious effect on fasting triglycerides and coronary artery disease risk profile ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP134056.RADnTQy8y3-vk1HeaUpncJ1cPxJ56KwqhlKUaIC60fuiM130_assertion description "[Combined with abdominal obesity, epistasis in the VLDL pathway (lipoprotein lipase, apolipoprotein CIII, hepatic lipase, PARalpha, PPARgamma, and apo E genes) has a deleterious effect on fasting triglycerides and coronary artery disease risk profile ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP134056.RADnTQy8y3-vk1HeaUpncJ1cPxJ56KwqhlKUaIC60fuiM130_provenance.
- NP197213.RAVDJ0a37G1KA-JVykof9NFagIyJp6SVC-SL9lmCPqqm0130_assertion description "[Combined with abdominal obesity, epistasis in the VLDL pathway (lipoprotein lipase, apolipoprotein CIII, hepatic lipase, PARalpha, PPARgamma, and apo E genes) has a deleterious effect on fasting triglycerides and coronary artery disease risk profile ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP197213.RAVDJ0a37G1KA-JVykof9NFagIyJp6SVC-SL9lmCPqqm0130_provenance.
- NP223254.RAxpFkb6hV2CeBJqHHrpEHm2ZUbSQtAia4TbwHcAnoE5w130_assertion description "[Combined with abdominal obesity, epistasis in the VLDL pathway (lipoprotein lipase, apolipoprotein CIII, hepatic lipase, PARalpha, PPARgamma, and apo E genes) has a deleterious effect on fasting triglycerides and coronary artery disease risk profile ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP223254.RAxpFkb6hV2CeBJqHHrpEHm2ZUbSQtAia4TbwHcAnoE5w130_provenance.